General
Preferred name
TRIAPINE
Synonyms
NSC663249 ()
PAN-811 ()
OCX191 ()
3-AP ()
Ocx 191 ()
OCX-0191 ()
NSC-663249 ()
OCX-191 ()
P&D ID
PD013043
CAS
143621-35-6
236392-56-6
200933-27-3
Tags
available
drug candidate
Drug indication
Nerve injury
Neoplasm
Drug Status
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Triapine (3-AP; PAN-811) is a potent inhibitor of the M2 subunit of ribonucleotide reductase (RR), and is a potent radiosensitizer.
PRICE 45
DESCRIPTION Potent and selective PLK1 inhibitor (Tocris Bioactive Compound Library)
DESCRIPTION 3-AP (Triapine) is a novel inhibitor of the M2 subunit of ribonucleotide reductase (RR). (TargetMol Bioactive Compound Library)
Cell lines
20
Organisms
0
Compound Sets
12
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
Pandemic Response Box
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
31
Properties
(calculated by RDKit )
Molecular Weight
195.06
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.17
TPSA
89.32
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.35
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
DNA/RNA Synthesis
RR
RRM1, RRM2
DNA/RNA Synthesis,RNR
Primary Target
Ribonucleotide Reductase
MOA
Inhibitor
Ribonucleotide Reductase inhibitor
Pathway
Cell Cycle/DNA Damage
Cell Cycle/Checkpoint
DNA Damage/DNA Repair
Source data